Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Brawn Biotech Ltd (NSE: BRAWN), ISIN INE899B01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BRAWN last traded at ₹21.50 (-2.49%), with a 52-week range of ₹17.71 to ₹24.37 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 53.39%, FIIs 0.00%, DIIs 0.35%, mutual funds 0.35%.
EquiSense Score (ECS): 66/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.